NI
DARE icon

Numeric Investors’s Dare Bioscience DARE Stock Holding History

Numeric Investors’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-716
Closed -$395K – 1017
2015
Q2 		$395K Buy
+716
New +$492K ﹤0.01% 715

Other funds holding DARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors's DARE Position: Q3 2015 in Review

Numeric Investors sold out of Dare Bioscience (DARE) in Q3 2015, closing a stake of 716 shares — an estimated $395K sold.

Numeric Investors first reported a position in DARE in Q2 2015 and held it in 1 quarter. The position peaked at $395K in Q2 2015. 38 funds tracked by Wall St. Rank hold DARE as of Q3 2015.

  • Numeric Investors reported no remaining Dare Bioscience position as of Q3 2015 after selling out during the quarter.
  • Numeric Investors sold 716 Dare Bioscience shares in Q3 2015, an estimated $395K.
  • Numeric Investors first reported a position in Dare Bioscience in Q2 2015 and held it in 1 quarter.
  • Numeric Investors's Dare Bioscience position peaked at $395K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2015.

Based on Numeric Investors's 13F filing for Q3 2015, filed 12 Nov 2015.